Replies to post #302503 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

I believe Fragile X and the other rare indication, probably Batten disease, will be initiated only after readout of EXCELLENCE because it will hopefully prove safety and provide more data for trial design of pivotal studies.